KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Astrana Health (ASTH) Shares Outstanding (Weighted Average) (2016 - 2025)

Astrana Health (ASTH) has disclosed Shares Outstanding (Weighted Average) for 16 consecutive years, with $49.1 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) rose 3.11% to $49.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $49.1 million through Dec 2025, up 3.11% year-over-year, with the annual reading at $49.1 million for FY2025, 3.11% up from the prior year.
  • Shares Outstanding (Weighted Average) hit $49.1 million in Q4 2025 for Astrana Health, roughly flat from $49.0 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $49.1 million in Q4 2025 to a low of $42.3 million in Q1 2021.
  • Historically, Shares Outstanding (Weighted Average) has averaged $46.2 million across 5 years, with a median of $46.6 million in 2023.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): grew 20.63% in 2021 and later rose 1.51% in 2024.
  • Year by year, Shares Outstanding (Weighted Average) stood at $43.8 million in 2021, then increased by 2.61% to $45.0 million in 2022, then grew by 3.52% to $46.6 million in 2023, then grew by 2.24% to $47.6 million in 2024, then rose by 3.11% to $49.1 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for ASTH at $49.1 million in Q4 2025, $49.0 million in Q3 2025, and $48.8 million in Q2 2025.